Forte Biosciences (FBRX) Net Income towards Common Stockholders (2016 - 2020)
Historic Net Income towards Common Stockholders for Forte Biosciences (FBRX) over the last 5 years, with Q1 2020 value amounting to -$9.4 million.
- Forte Biosciences' Net Income towards Common Stockholders rose 4500.7% to -$9.4 million in Q1 2020 from the same period last year, while for Dec 2020 it was -$9.4 million, marking a year-over-year increase of 8520.85%. This contributed to the annual value of -$63.5 million for FY2019, which is 2974.36% down from last year.
- Per Forte Biosciences' latest filing, its Net Income towards Common Stockholders stood at -$9.4 million for Q1 2020, which was up 4500.7% from -$10.6 million recorded in Q4 2019.
- Over the past 5 years, Forte Biosciences' Net Income towards Common Stockholders peaked at -$383000.0 during Q3 2018, and registered a low of -$19.6 million during Q4 2018.
- In the last 5 years, Forte Biosciences' Net Income towards Common Stockholders had a median value of -$10.0 million in 2017 and averaged -$11.4 million.
- In the last 5 years, Forte Biosciences' Net Income towards Common Stockholders surged by 9615.19% in 2018 and then crashed by 479164.49% in 2019.
- Quarter analysis of 5 years shows Forte Biosciences' Net Income towards Common Stockholders stood at -$8.5 million in 2016, then dropped by 28.08% to -$10.8 million in 2017, then crashed by 80.89% to -$19.6 million in 2018, then soared by 46.01% to -$10.6 million in 2019, then grew by 11.23% to -$9.4 million in 2020.
- Its Net Income towards Common Stockholders was -$9.4 million in Q1 2020, compared to -$10.6 million in Q4 2019 and -$18.7 million in Q3 2019.